Yu Chen

42PUBLICATIONS

270CO-AUTHORS

Molecular targetsPredictive and prognostic markersLiquid biopsiesCancer diagnosisEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (42)

Sort by Publication Date:

|Jul 01, 2026

Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

|May 18, 2026

Dependencies in heterogeneous, lineage plastic patient-derived prostate cancer organoids revealed through integrated single-cell multiomics and CRISPR screening.

|Mar 14, 2026

Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness.

Michel Kahi, Abigail Mazzu, Ludovic Batistic

|Feb 27, 2026

Cell-Autonomous AR Dependence in Luminal Prostatic Epithelium Governs Survival and Lineage Plasticity.

Dan Li, Naitao Wang, Wangxin Guo

|Jan 14, 2026

A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

Phillip Thienger, Irene Paassen, Xiaosai Yao

|Nov 26, 2025

NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Jia J Li, Alessandro Vasciaveo, Dimitris Karagiannis

Pageof 7

Frequent Collaborators

12 joint publications

Dan Li

Charles Sawyers

Wangxin Guo

Ping Chi

Himisha Beltran

Ekta Khurana

Fei Li

David B Solit

Amanda R Moore

Thomas P Sakmar

Frequent Collaborators

12 joint publications

Dan Li

9 joint publications

Charles Sawyers

8 joint publications

Wangxin Guo

6 joint publications

Ping Chi